Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-05Clinical Trial Update: National, Multicentric Registry Study on Neuroimmunological Diseases in China
National multicentric registry in China studying neuroimmunological diseases is currently recruiting, covering conditions such as Multiple S…
-
CLINICAL_TRIALS research · 2024-06-05Clinical Trial Update: High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis [NA]
Clinical trial NCT05735691 on high-intensity dynamic-stability gait training for people with Multiple Sclerosis is currently RECRUITING at M…
-
CLINICAL_TRIALS research · 2024-06-03Clinical Trial Update: Conventional Vestibular Training Versus Immersive Virtual Reality- Based Vestibular in Multiple Sclerosis [NA]
A clinical trial compares conventional vestibular training with immersive virtual reality–based vestibular training in people with Multiple …
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: Mechanistic Study of Ocrevus
Completed clinical trial update on a mechanistic study of Ocrevus (ocrelizumab) in multiple sclerosis.
-
FDA approval · 2024-05-30FDA Approved: FINGOLIMOD HYDROCHLORIDE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for fingolimod hydrochloride from Accord Healthcare Inc., enabling the generic version of the multip…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-05-30FDA Approved: FINGOLIMOD — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for fingolimod hydrochloride (Fingolimod) submitted by Ascend Laboratories, LLC under ANDA208004.
-
FDA approval · 2024-05-29FDA Approved: FINGOLIMOD — Supplemental Application (XLCare Pharmaceuticals Inc.)
FDA approved a supplemental application for fingolimod from XLCare Pharmaceuticals Inc., indicating regulatory approval of a supplemental su…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis [NA]
A clinical trial is assessing the acceptability of exoskeleton-assisted walking for people with mobility issues due to Multiple Sclerosis an…
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: Cognition and HRQoL in Adults With Highly-active RMS in Year 3 and 4 After Initial Mavenclad® Dose (CLARIFY MS Extension) [Phase 4]
This Phase 4 extension study (CLARIFY MS Extension) evaluated cognition and health-related quality of life in adults with highly-active rela…
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: Rex Robot Assisted Rehabilitation to Enhance Balance and Mobility for People With Multiple Sclerosis, Clinical and Biomarker Study - RAPPER IV [Phase 1]
Phase 1 trial update on Rex robot-assisted rehabilitation to enhance balance and mobility in people with Multiple Sclerosis; the study has c…
-
CLINICAL_TRIALS research · 2024-05-24Clinical Trial Update: The Efficacy of Tele Rehabilitation- Based Task-Specific Training for Cognitive Function Improvement [NA]
A clinical trial is evaluating tele-rehabilitation-based task-specific training to improve cognitive function in people with multiple sclero…
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: Prebiotic vs Probiotic in Multiple Sclerosis [NA]
A completed clinical trial comparing prebiotic versus probiotic interventions in individuals with Multiple Sclerosis and Clinically Isolated…
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: The Effects of Two Types of t-DCS Stimulation on Robot-assisted Gait Training in Patients With Multiple Sclerosis [NA]
This clinical trial update reports a study evaluating two types of transcranial direct current stimulation (t-DCS) combined with robot-assis…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: LONG-TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELIZUMAB [Phase 3]
Phase 3 long-term evaluation of the effectiveness and safety of ocrelizumab for multiple sclerosis; the trial is currently active but not re…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: A Study to Explore Association Patterns Between Digital Outcome Assessments From the Konectom™ Platform and Magnetic Resonance Imaging (MRI) Measures of Brain Tissue Damage
Biogen-sponsored study completed to explore how digital outcome assessments from the Konectom platform relate to MRI measures of brain tissu…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Use of Audio Recordings of Self-Hypnosis and Meditation for Fatigue Management in Multiple Sclerosis [NA]
This update reports the completion of a clinical trial evaluating audio recordings of self-hypnosis and meditation for fatigue management in…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Trial of eHealth Wellness Behavioral Interventions and Patient-reported Outcomes [NA]
The clinical trial evaluating eHealth wellness behavioral interventions and patient-reported outcomes for multiple sclerosis has been comple…
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Use of a Smartphone Application to Predict the Prognosis in Patients With Newly Diagnosed Multiple Sclerosis.
This entry provides an update on an ongoing clinical trial evaluating a smartphone application to predict prognosis in patients newly diagno…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses [Phase 4]
A Phase 4 study assessed ACTHAR's effects on MRI-based disease activity markers and immune signatures during Multiple Sclerosis relapses. Th…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Prescription Drug Safety and Effectiveness in Multiple Sclerosis
The document reports completion of a clinical trial evaluating the safety and effectiveness of a prescription drug in adults with multiple s…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
Post-authorization safety study assessing pregnancy outcomes in patients treated with Mayzent (fingolimod) for multiple sclerosis. The study…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: The Effect of a Mindfulness-Based Stress Reduction Program in Patients With Multiple Sclerosis [NA]
The clinical trial investigating a mindfulness-based stress reduction program in patients with Multiple Sclerosis has completed.
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Home-based Balance Training in Adults With Multiple Sclerosis [NA]
University of Vermont is conducting a clinical trial to evaluate home-based balance training for adults with Multiple Sclerosis; the study i…
-
FDA approval · 2024-05-14FDA Approved: FINGOLIMOD — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved the supplemental application for fingolimod hydrochloride, enabling a generic version of the multiple sclerosis drug fingolimod…
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: Serum Neurofilament-light Chain and GFAP Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis
This clinical trial update investigates serum neurofilament-light chain and GFAP levels in people with multiple sclerosis from the OFSEP coh…